Optimal Blood Pressure Cut-Off for Preventing Heart Disease and Death

Study Overview

In a recent study published in JAMA Internal Medicine, researchers explored the ideal cut-off for measuring blood pressure across various hypertension categories to mitigate the risks of death and heart disease. The research, conducted by Mattias Brunström and Bo Carlberg, utilized previous systematic reviews sourced from platforms like PubMed, the Cochrane Database of Systematic Reviews, and the Database of Abstracts of Reviews of Effect.

Methodology

The researchers focused on randomized controlled trials published after November 2015. The inclusion criteria emphasized studies with a substantial number of participants and a minimum of 1,000 patient-years of follow-up. This comprehensive review led to a meta-analysis that incorporated data from approximately 74 trials, representing a total of 306,273 participants and equating to 1.2 million patient-years.

Findings on Systolic Blood Pressure

The study identified starting systolic blood pressure as a crucial factor in assessing major cardiovascular events in patients receiving blood pressure-lowering medications. Systolic blood pressure is defined as the maximum pressure exerted by the heart to circulate blood throughout the body, typically ranging from 80 to 120 mmHg. Individuals with readings outside this range face an increased risk of cardiovascular disease and may need medication.

Impact of Blood Pressure on Mortality and Cardiovascular Risk

The research highlighted that the risk of death and heart disease significantly decreased only when the initial systolic blood pressure was 140 mmHg or higher prior to treatment. Specifically, patients with a starting blood pressure of 160 mmHg or above observed a marked reduction in cardiovascular risk when appropriately treated. Conversely, those with baseline blood pressure between 140 to 159 mmHg experienced a similar mortality association post-medication, despite a reduction in cardiovascular events.

For individuals whose initial blood pressure was below 140 mmHg, the study found that medication did not substantially lower mortality rates or decrease major cardiovascular risk.

Conclusion

The researchers successfully established a correlation between blood pressure reduction and decreased mortality and cardiovascular disease risk. They concluded that a systolic blood pressure of 140 mmHg or higher before treatment is critical for significant health benefits. In contrast, levels below this threshold appeared ineffective in influencing mortality or cardiovascular disease risk.

Authorship

This article was written by Dr. Apollina Sharma, MBBS, GradDip EXMD.

Related Topics

– Does high blood pressure increase the risk of miscarriage?
– Can a common blood pressure drug improve ovarian cancer treatment?
– Could blood pressure treatment be harmful to older seniors?
– Is poor oral health linked to worse blood pressure control?
– Nitrate-rich vegetables and the lowering of blood pressure myth
– Can dementia be prevented with stricter blood pressure control?

Reference

Brunström, Mattias, and Bo Carlberg. “Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis.” JAMA Internal Medicine 178.1 (2018): 28-36.